Chronic kidney disease and hypertension
Clinical trials for Chronic kidney disease and hypertension explained in plain language.
Never miss a new study
Get alerted when new Chronic kidney disease and hypertension trials appear
Sign up with your email to follow new studies for Chronic kidney disease and hypertension, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo pill aims to protect kidneys in High-Risk patients
Disease control OngoingThis study tests whether adding dapagliflozin to baxdrostat reduces protein in the urine (a sign of kidney damage) better than baxdrostat alone. About 218 adults with chronic kidney disease and high blood pressure will take either the combo or baxdrostat plus a placebo. The goal …
Matched conditions: CHRONIC KIDNEY DISEASE AND HYPERTENSION
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a Two-Drug punch protect kidneys in High-Risk patients?
Disease control OngoingThis phase 3 study tests whether adding baxdrostat to the standard drug dapagliflozin can better slow chronic kidney disease (CKD) progression in adults with CKD and high blood pressure. About 2,500 participants will receive either the combination or dapagliflozin alone for 24 mo…
Matched conditions: CHRONIC KIDNEY DISEASE AND HYPERTENSION
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC